|4 April 2017|
Royal DSM has opened a state-of-the-art biotechnology hub in Delft to help tackle some of the world’s most pressing challenges.
A truly international affair, the new site, which has attracted 400 scientists from 27 countries, is part of the company’s €100 million investment initiative – started in 2013 – to ramp up its R&D spend in the country.
“DSM’s new Biotechnology Center is where our scientists create solutions for societal challenges such as the need to provide all people globally with nutritious food, as well as enabling the transformation from a fossil-based to a bio-renewable-based society.The DSM Biotechnology Center facilitates these needs, in an innovative environment and at an historic location in Delft where we build on nearly 150 years of scientific, academic and commercial activities,” said Feike Sijbesma, CEO/Chairman of the DSM Managing Board.
It will be called the Rosalind Franklin Biotechnology Center after innovative scientist Rosalind Franklin (1920-1958).